De-Cell-eration in Therapy for Diffuse Large B-Cell Lymphoma

被引：3
|
作者：
Leonard, John P. [1 ,2 ]
机构：
[1] Weill Cornell Med, 1305 York Ave,7th Floor, New York, NY 10021 USA
[2] New York Presbyterian Hosp, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
CHEMOTHERAPY PLUS RITUXIMAB; OPEN-LABEL; CHOP; TRANSPLANTATION; MULTICENTER; OUTCOMES;
D O I：
10.1200/JCO.19.00445
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1267 / +
页数：4
相关论文
共 50 条
  • [31] Benefit of Consolidative Radiation Therapy for Primary Bone Diffuse Large B-Cell Lymphoma
    Tao, Randa
    Allen, Pamela K.
    Rodriguez, Alma
    Shihadeh, Ferial
    Pinnix, Chelsea C.
    Arzu, Isadora
    Reed, Valerie K.
    Oki, Yasuhiro
    Westin, Jason R.
    Fayad, Luis E.
    Medeiros, L. Jeffrey
    Dabaja, Bouthaina
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 92 (01): : 122 - 129
  • [32] NOVEL THERAPIES IN THE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA
    Carlo-Stella, C.
    Calabretta, E.
    HAEMATOLOGICA, 2021, 106 (10) : 201 - 202
  • [33] Diffuse Large B-Cell Lymphoma in the Older and Frail Patient
    Ayers, Emily C.
    Smith, Sonali M.
    CANCERS, 2025, 17 (05)
  • [34] Postrelapse survival in diffuse large B-cell lymphoma after therapy failure following autologous transplantation
    Epperla, Narendranath
    Badar, Talha
    Szabo, Aniko
    Vaughn, John
    Borson, Steve
    Saini, Neeraj Y.
    Patel, Romil D.
    Shah, Nirav N.
    Hamadani, Mehdi
    Ahmed, Sairah
    Cashen, Amanda F.
    Fenske, Timothy S.
    BLOOD ADVANCES, 2019, 3 (11) : 1661 - 1669
  • [35] Sequencing of cellular therapy and bispecific antibodies for the management of diffuse large B-cell lymphoma
    Melody, Megan
    Gordon, Leo I.
    HAEMATOLOGICA, 2024, 109 (10) : 3138 - 3145
  • [36] Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma
    Bartlett, Nancy L.
    Assouline, Sarit
    Giri, Pratyush
    Schuster, Stephen J.
    Cheah, Chan Y.
    Matasar, Matthew
    Gregory, Gareth P.
    Yoon, Dok Hyun
    Shadman, Mazyar
    Fay, Keith
    Yoon, Sung-Soo
    Panizo, Carlos
    Flinn, Ian
    Johnston, Anna
    Bosch, Francesc
    Sehn, Laurie H.
    Wei, Michael C.
    Yin, Shen
    To, Iris
    Li, Chi-Chung
    Huang, Huang
    Kwan, Antonia
    Penuel, Elicia
    Budde, Lihua E.
    BLOOD ADVANCES, 2023, 7 (17) : 4926 - 4935
  • [37] ABCs of ADCs in management of relapsed/refractory diffuse large B-cell lymphoma
    Alderuccio, Juan Pablo
    Sharman, Jeff P.
    BLOOD REVIEWS, 2022, 56
  • [38] CD19-Targeted Immunotherapies for Diffuse Large B-Cell Lymphoma
    Gambella, Massimiliano
    Carlomagno, Simona
    Raiola, Anna Maria
    Giannoni, Livia
    Ghiggi, Chiara
    Setti, Chiara
    Giordano, Chiara
    Luchetti, Silvia
    Serio, Alberto
    Bo, Alessandra
    Falco, Michela
    Della Chiesa, Mariella
    Angelucci, Emanuele
    Sivori, Simona
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [39] Examining racial differences in diffuse large B-cell lymphoma presentation and survival
    Flowers, Christopher R.
    Shenoy, Pareen J.
    Borate, Uma
    Bumpers, Kevin
    Douglas-Holland, Tanyanika
    King, Nassoma
    Brawley, Otis W.
    Lipscomb, Joseph
    Lechowicz, Mary Jo
    Sinha, Rajni
    Grover, Rajinder S.
    Bernal-Mizrachi, Leon
    Kowalski, Jeanne
    Donnellan, Will
    The, Angelina
    Reddy, Vishnu
    Jaye, David L.
    Foran, James
    LEUKEMIA & LYMPHOMA, 2013, 54 (02) : 268 - 276
  • [40] The future of immunotherapy for diffuse large B-cell lymphoma
    Duell, Johannes
    Westin, Jason
    INTERNATIONAL JOURNAL OF CANCER, 2025, 156 (02) : 251 - 261
12345